Alopecia Areata

Cutis

Volumn 59, Issue 5, 1997, Pages 238-241

  Schwartz, Robert A ^a   Janniger, Camila Krysicka ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALOPECIA AREATA; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; NAIL DISEASE; PRESCHOOL CHILD; REVIEW; THYROID DISEASE;

ADOLESCENT; ADULT; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; NAILS, MALFORMED; THYROID DISEASES;

EID: 0031137305     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Zak-Prelich M, Broniarczyk-Dyla G, Niewiadomska H: The results of diphencyprone treatment in alopecia areata. Clinical and immunological evaluations. Przegl Dermatol 82: 563-570, 1995.
2. Roselino AM, Almeida AM, Hippolito MA, et al: Clinico-epidemiologic study of alopecia areata. Int J Dermatol 35: 181-184, 1996.
3. Sharma VK, Dawn G, Kumar B: Profile of alopecia areata in northern India. Int J Dermatol 35: 22-27, 1996.
4. Sharma VK, Kumar B, Dawn G: A clinical study of childhood alopecia areata in Chandigarh, India. Pediat Dermatol 13: 372-377, 1996.
5. Szepietowski J, Bielecka E, Szybejko-Machaj G, et al: Coexistence of lichen planus and alopecia areata. A case report. Przegl Dermatol 83: 223-227, 1996.
6. Ghersetich I, Campanile G, Lotti T: Alopecia areata: immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors. Int J Dermatol 35: 28-33, 1996.
7. Hoffmann R, Wenzel E, Huth A, et al: Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 103: 530-533, 1994.
8. Ro BI: Alopecia areata in Korea. J Dermatol (Tokyo) 22: 858-864, 1995.
9. Colombe BW, Price VH, Khoury EL, et al: HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 33: 757-764, 1995.
10. Wygledowska-Kania M, Bogdanowski T: Examination of the significance of psychological factors in the etiology of alopecia areata. I. Examining type A behavior. Przegl Lekarski 52: 311-314, 1995.
11. Kumar B, Sharma VK, Sehgal S: Antismooth muscle and antiparietal cell antibodies in Indians with alopecia areata. Int J Dermatol 34: 542-545, 1995.
12. 2nd International Research Workshop on Alopecia Areata. Bethesda, Maryland, November 7-8, 1994. J Invest Dermatol 104 (5 suppl): 1S-45S, 1995.
13. Corazza GR, Andreani ML, Venture N, et al: Celiac disease and alopecia areata: report of a new association. Gastroenterology 109: 1333-1337, 1995.
14. Janniger CK: Alopecia areata. Cutis 50: 347-349, 1992.
15. Hara M, Hunayama M, Aida S, et al: Acrokeratosis paraneoplastica (Bazex syndrome) associated with primary cutaneous squamous cell carcinoma on the lower leg, vitiligo and alopecia areata. Br J Dermatol 133: 121-124, 1995.
16. Jautova J, Jarcuskova D, Dubivska M, et al: Immunostimulation therapy in patients with alopecia areata. Bratislav Lekarske Listy 96: 160-164, 1995.
17. Loza K, Borzecki A, Chwaluk J: TFX treatment of patients with generalized alopecia areata. In, Congressus Dermatologiae 23-25.06.1995 Lódz, Streszczenie referatów (Omulecki A, ed). Warsaw, SB Publications, 1995, p 83.
18. Sahn EE: Alopecia areata in childhood. Semin Dermatol 14: 9-14, 1995.
19. Cho M, Cohen PR, Duvic M: Vitiligo and alopecia areata in patients with human immunodeficiency virus infection. South Med J 88: 489491, 1995.
20. Tosti A, Morelli R, Bardazzi F, et al: Prevalence of nail abnormalities in children with alopecia areata. Pediat Dermatol 11: 112-115, 1994.
21. Drake LA, Ceilley RI, Cornelison RL, et al: Guidelines of care for alopecia areata. J Am Acad Dermatol 26: 247-250, 1992.
22. Price VH: Alopecia areata: clinical aspects. J Invest Dermatol 96: 68S, 1992.
23. Zak-Prelich M, Broniarczyk-Dyla G: Dystrophic nail changes in alopecia areata. Przegl Dermatol 80: 240-244, 1993.
24. Simpson NB: Alopecia areata. In, Diseases of the Hair and Scalp, 2nd ed (Rook A, Dawber R, eds), p 296. London, Blackwell Scientific Publications, 1991.
25. Simpson NB: Diffuse alopecia: endocrine, metabolic and chemical influences on the follicular cycle. In, Diseases of the Hair and Scalp, 2nd ed (Rook A, Dawber R, eds), p 136. London, Blackwell Scientific Publications, 1991.
26. Perret CM, Steijlen PM, Happle R: Alopecia areata. Pathogenesis and topical immunotherapy. Int J Dermatol 29: 83-88, 1990.
27. Jazienicka I, Chibowska M: The involvement of bioelements in the pathogenesis of alopecia areata. In, Congressus Dermatologiae 23-25.06,1995 Lódz. Streszczenie referatów (Omulecki A, ed). Warsaw, SB Publications, 1995, p 85.
28. Guin JD, Kumar V, Petersen BH: Immunofluorescence findings in rapid whitening of the scalp hair. Arch Dermatol 117: 576-578, 1981.
29. Crosby DL, Gammon WR: Seasonal alopecia areata with atopy. J Am Acad Dermatol 21: 806-807, 1989.
30. Tosti A, Fanti PA, Morelli R, et al: Trachyonychia associated with alopecia areata: a clinical and pathological study. J Am Acad Dermatol 25: 266-270, 1991.
31. Lewinski A, Broniarczyk-Dyla G, Sewerynek E, et al: Abnormalities in structure and function of the thyroid gland in patients with alopecia areata. J Am Acad Dermatol 23: 768-769, 1990.
32. Milgraum SS, Mitchell AJ, Bacon GE, et al: Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am Acad Dermatol 17: 57-61, 1987.
33. Werth VP, White WL, Sanchez MH, et al: Incidence of alopecia areata in lupus erythematosus. Arch Dermatol 128: 368-371, 1992.
34. Tobin DJ, Bystryn J-C: Immunology to hair follicles in alopecia areata. J Invest Dermatol 104 (5 suppl): 13S-14S, 1995.
35. McDonagh AJG, Elliott KR, Messenger AG: Cytokines and dermal papilla function in alopecia areata. J Invest Dermatol 104 (5 suppl): 9S-10S, 1995.
36. Norris DA, Duke R, Whang K, et al: Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata. J Invest Dermatol 104 (5 suppl): 8S-9S, 1995.
37. McElwee KJ, Pickett P, Oliver RF: The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol 134: 55-63, 1996.
38. Hull SM, Nutbrown M, Pepall L, et al: Immunohistological and ultrastructural comparison of the dermal papilla and hair follicle bulb form "active" and "normal" areas of alopecia areata. J Invest Dermatol 96: 673-681, 1991.
39. Khoury EL, Price VH, Abdel-Salam MM, et al: Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration. J Invest Dermatol 99: 4047, 1992.
40. Duvic M, Welsh EA, Jackow C et al: Analysis of HLA-D locus alleles in alopecia areata patients and families. J Invest Dermatol 104 (5 Suppl): 5S-6S, 1995.
41. Helm F, Milgrom H: Can scalp hair suddenly turn white? A case of canities subita. Arch Dermatol 102: 102-104, 1970.
42. Ackerman AB: Histological Diagnosis of Inflammatory Skin Diseases. A Method by Pattern Analysis. Philadelphia, Lea & Febiger, 1978.
43. Dawber RPH: The comparative physiology, embrology and physiology of human hair. In, Diseases of the Hair and Scalp, 2nd ed (Rook A, Dawber R, eds), p 1. London, Blackwell Scientific Publications, 1991.
44. Whiting DA: The histopathology of alopecia areata in horizontal sections of scalp biopsies. J Invest Dermatol 104 (5 suppl): 26S-27S, 1995.
45. Sperling LC, Lupton GP: Histopathology of non-scarring alopecia. J Cutan Pathol 22: 97-114, 1995.
46. Pramatarov K, Vasileva S, Tzankov N: Alopecia psoriatica. Dermatol Venereol (Sofia) 24: 18-20, 1995.
47. Kligman AM: Pathologic dynamics of reversible hair loss in humans. I. Telogen effluvium. Arch Dermatol 83: 175-179, 1961.
48. Armstrong DKB, Burrows D: Congenital triangular alopecia. Pediat Dermatol 13: 394-396, 1996.
49. Carson HJ, Pellettiere EV, Lack E: Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast cancer. J Cutan Pathol 21: 67-70, 1994.
50. Schwartz RA: Cutaneous metastatic disease. J Am Acad Dermatol 33: 161-182, 1995.
51. Schwartz RA: Arsenic and the skin. Int J Dermatol (in press).
52. Taylor CR, Hawk JL: PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St. John's Institute of Dermatology. Br J Dermatol 133: 914-918, 1995.
53. Shapiro J, Tan J, Ho V, et al: Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic study. J Invest Dermatol 104: (5 suppl): 36S, 1995.
54. Orecchia G, Malagoli P: Topical immunotherapy in children with alopecia areata. J Invest Dermatol 104: (5 suppl): 35S-36S, 1995.
55. van Baar BM, van der Vleuten CJ, van de Kerkhof PC: Dapsone versus topical immunotherapy in alopecia areata. Br J Dermatol 133: 270-274, 1995.
56. Lei Y, Nie Y-F, Zhang J-M, et al: Effect of superficial hypothermic cryosurgery with liquid nitrogen in alopecia areata. Arch Dermatol 127: 1851-1852, 1991.
57. Kuflik EG: Cryosurgery updated. J Am Acad Dermatol 31: 925-944, 1994.
58. Zuchowska J, Neumann E: The treatment of various types of alopecia with topical minoxidil. Postepy Dermatol (Poznan) 6: 587-597, 1989.
59. Alexiewicz M: Minoxidil in treatment of different hair loss. In, Congressus Dermatologiae 23-25.06,1995 Lódz. Streszczenie referatów. (Omulecki A, ed). Warsaw, SB Publications, 1995, p 82.
60. Alexiewicz M: Sprawozdanie z International Meeting "Skin therapy update 94" 14-17 October, Aghia Pelaghia, Crete, Greece. Postepy Dermatol (Poznan) 12: 253-254, 1995.
61. Kagoura M, Hino T, Nakamura M, et al: Treatment of alopecia areata in our dermatology clinic. Acta Dermatol (Kyoto) 90: 205-209, 1995.
62. Henderson CA, Ilchyshyn A: Vitiligo complicating diphenylcyclopropenone sensitization therapy for alopecia universalis. Br J Dermatol 133: 496-497, 1995.
63. Micali G, Licastro Cicero R, Nasca MR, et al: Treatment of alopecia areata with squaric acid dibutylester. Int J Dermatol 35: 52-56, 1996.
64. Fiedler VC, Wendrow A, Szpunar GJ, et al: Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. Arch Dermatol 126: 756-759, 1990.
65. Jendryczko A, Bogdanowski T, Szpyrka B: Zinc, copper and selenium levels in serum, erythrocytes, hair and 24-hour urine of alopecia children. Przegl Dermatol 80: 513-517, 1993.
66. Szachtmejster IJ, Riabinina ME, Dandaszli AM: Alopecia treated with zincteral. In, Advances in the Pathogenesis, Diagnosis, and Treatment of Skin and Venereol Diseases. Proceedings of the 24th Congress of the Polish Dermatologic Society. Gdansk 1992.09.24-26. (Szarmach H, ed). Gdansk, Drukarnia Archidiecezji Gdanskiej, 1992, p 768.
67. Placek W, Jasiel E, Siedlewicz A: Alopecia areata treatment results in patients of the Dermatology Clinic, Medical University of Gdansk. In, Congressus Dermatologiae 23-25.06.1995 Lódz, Streszczenie referatów (Omulecki A, ed). Warsaw, SB Publications, 1995, p 309 (abstract).
68. de Misa RF, Sánchez E, Azaña JM, et al: Unsuccessful treatment of alopecia universalis with subcutaneous interferon-alpha-2a. J Dermatol Treat 5: 111, 1994 (letter).
69. Schuttelaar M-LA, Hamstra JJ, Plinck EPB, et al: Alopecia areata in children: treatment with diphencyprone. Br J Dermatol 135: 581-585, 1996.
70. Alabdulkareem AS, Abahussein AA, Okoro A: Minimal benefit from protochemotherapy for alopecia areata. Int J Dermatol 35: 890-891, 1996.
71. Broniarczyk-Dyla G, Zak-Prelich M: The results of the treatment of alopecia areata with 2% minoxidil solution and anthralin. Postepy Dermatol (Poznan) 13: 29-33, 1996.